SDS

Page 8 / 13
Rechargeable Li-ion Polymer Battery MLP553851
Revision Date 10-October-2017
Hives.
Delayed and immediate effects as well as chronic effects from short and long-term exposure
Sensitization May cause sensitization of susceptible persons. May cause sensitization by skin contact.
Mutagenic Effects No information available.
Carcinogenicity The table below indicates whether each agency has listed any ingredient as a carcinogen.
Chemical Name
ACGIH
IARC
NTP
OSHA
Lithium Cobalt Oxide
(CoLiO2)
12190-79-3
A3
Group 2B
X
Carbon black
1333-86-4
A3
Group 2B
X
Nickel
7440-02-0
Group 2B
Reasonably Anticipated
X
ACGIH (American Conference of Governmental Industrial Hygienists)
A3 - Animal Carcinogen
IARC (International Agency for Research on Cancer)
Group 2B - Possibly Carcinogenic to Humans
Group 3 - Not Classifiable as to Carcinogenicity in Humans
NTP (National Toxicology Program)
Reasonably Anticipated - Reasonably Anticipated to be a Human Carcinogen
OSHA (Occupational Safety and Health Administration of the US Department of Labor)
X - Present
Reproductive Toxicity No information available.
STOT - single exposure No information available.
STOT - repeated exposure Causes damage to organs through prolonged or repeated exposure. Based on
classification criteria from the 2012 OSHA Hazard Communication Standard (29 CFR
1910.1200), this product has been determined to cause systemic target organ toxicity from
chronic or repeated exposure. (STOT RE).
Chronic Toxicity Contains a known or suspected carcinogen. Avoid repeated exposure. Prolonged exposure
may cause chronic effects. May cause adverse liver effects. Carbon black has been
classified by the International Agency for Research on Cancer (IARC) as possibly
carcinogenic to humans (Group 2B) by inhalation.
Target Organ Effects Respiratory system. Eyes. Skin. Gastrointestinal tract (GI). Central Vascular System (CVS).
Kidney. Liver. Lungs.
Aspiration Hazard No information available.
Numerical measures of toxicity Product Information
The following values are calculated based on chapter 3.1 of the GHS document
ATEmix (oral)
16,500.00 mg/kg
ATEmix (dermal)
9,900.00 mg/kg (ATE)